Clinical Trials
3 trialsNCT04098068 2025-03-30
Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT03374254 2024-11-21
KEYNOTE-651
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT03631407 2024-11-21
MK-7690-046
Merck Sharp & Dohme LLC
Phase 2 Completed